The Oxford Martin School, Liverpool School of Tropical Medicine and the UK Centre for Ecology & Hydrology invite you to a panel discussion during World Antibiotic Awareness Week on new solutions to the stalled antibiotic research and development (R&D) pipeline.
This event is organised by the Oxford Martin Programme on Collective Responsibility for Infectious Disease.
Over the past three decades, the rapid rise of antimicrobial resistance and the lack of new antibiotics have created a perfect storm for global health and food systems. Antibiotic effectiveness is an endangered global common resource in urgent need of new solutions to protect existing drugs and to develop novel compounds.
This event brings together experts from the medical, natural, and social sciences to discuss both the status quo and new approaches to global drug development and stewardship. In addition to the current focus on using public money to reinvigorate private drug development, panellists will discuss alternatives such as a public buyout of existing patents and a long-term (inter)nationalisation of antibiotic development as well as solutions for the dilemma of curbing AMR and enhancing global access to effective antimicrobials.
5:00 – 5:15pm: (Inter)nationalising the antibiotic pipeline: public options for antibiotic R&D
Dr Andrew Singer (microbiologist, UK Centre for Ecology & Hydrology), Dr Claas Kirchhelle (historian, Oxford Martin School), Dr Adam Roberts (microbiologist, Liverpool School of Tropical Medicine) will introduce their new publication on public options for antibiotic development in Lancet Infectious Diseases.
5:15 – 6:00pm: Panel discussion with questions from the audience
An expert panel will discuss the economic, social, and microbiological dimensions of drug development, stewardship, and infection control in the 20th and 21st centuries:
Ellen Silbergeld (environmental and public health, Johns Hopkins University),
Koen Pouwels (modeller and economist, University Oxford),
Viviane Quirke (historian, Oxford Brookes University),
Javier Lezaun (social scientist, Institute for Science, Innovation, and Society, Oxford)
Nicola Elvis (microbiologist, Public Health England).
More information can be found here: www.oxfordmartin.ox.ac.uk/events/antibiotics-panel